Meng-zhu Shen
Beijing Key Laboratory Of Cell And Gene Therapy For Hematologic Malignancies
Beijing, 100044, China
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The PI3K-AKT pathway mediates the imbalance of bone marrow macrophage polarization in patients with immune thrombocytopenia.
Journal: Journal of translational medicine
Published: February 05, 2026
Hematopoiesis could be improved by correcting aberrant bone marrow macrophages polarization in aplastic anemia patients.
Journal: Science China. Life sciences
Published: June 23, 2025
TGF-β1-triggered maladaptive bone marrow endothelium impedes hematopoietic recovery.
Journal: Signal transduction and targeted therapy
Published: April 06, 2025
Inhibition of TGF-β signaling in bone marrow endothelial cells promotes hematopoietic recovery in acute myeloid leukemia patients.
Journal: Cancer letters
Published: September 12, 2024
TGF-β inhibition restores hematopoiesis and immune balance via bone marrow EPCs in aplastic anemia.
Journal: Experimental & molecular medicine
Published: August 19, 2024
HSPG2 could promote normal haematopoiesis in acute myeloid leukaemia patients after complete remission by repairing bone marrow endothelial progenitor cells.
Journal: Clinical and translational medicine
Published: August 06, 2024
Bone Marrow Endothelial Progenitor Cells remodelling facilitates normal hematopoiesis during Acute Myeloid Leukemia Complete Remission.
Journal: Nature communications
Published: February 12, 2024
Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation.
Journal: Blood science (Baltimore, Md.)
Published: July 10, 2023
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
Journal: Annals of hematology
Published: September 12, 2022
Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis.
Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis.
Journal: Frontiers in immunology
Published: May 27, 2022
A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation.
Journal: Experimental hematology & oncology
Published: February 07, 2022
Last Updated: 09/26/2026